Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patients

European Neuropsychopharmacology

Volumn 15, Issue 5, 2005, Pages 557-561

  Schwartz, Karin ^a   Iancu, Iulian ^a   Stryjer, Rafael ^a   Chelben, Joseph ^a   Kotler, Moshe ^a   Weizman, Abraham ^a   Rehavi, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Platelet; Schizophrenia; Smoking; Vesicular monoamine transporter

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; CLOTIAPINE; CLOZAPINE; DIAZEPAM; FLUPHENAZINE DECANOATE; FLUVOXAMINE; HALOPERIDOL; LEVOMEPROMAZINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PENFLURIDOL; PERPHENAZINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; VESICULAR MONOAMINE TRANSPORTER; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; THROMBOCYTE;

ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; BLOOD PLATELETS; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SMOKING;

EID: 24044522509     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.02.005     Document Type: Article

References (29)

1. S. Beratis, A. Katrivanou, and P. Gourzis Factors affecting smoking in schizophrenia Compr. Psychiatry 42 2001 393 402
2. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
3. C.R. Breese, M.J. Lee, C.E. Adams, B. Sullivan, J. Logel, K.M. Gillen, M.J. Marks, A.C. Collins, and S. Leonard Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia Neuropsychopharmacology 23 2000 351 364
4. A.L. Brody, R.E. Olmstead, E.D. London, J. Farahi, J.H. Meyer, P. Grossman, G.S. Lee, J. Huang, E.L. Hahn, and M.A. Mandelkern Smoking-induced ventral striatum dopamine release Am. J. Psychiatry 161 2004 1211 1218
5. A.M. Cesura, B. Bertocci, and M. Da Prada Binding of [3H] dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles Eur. J. Pharmacol. 186 1990 95 104
6. G.W. Dalack, D.J. Healy, and J.H. Meador-Woodruff Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings Am. J. Psychiatry 155 1998 1490 1501
7. A. Dervaux, F.J. Bayle, X. Laqueille, M.C. Bourdel, M.H. Le Borgne, J.P. Olie, and M.O. Krebs Nicotine use in schizophrenia and disinhibition Psychiatry Res. 128 2004 229 234
8. R.H. Edwards The transport of neurotransmitters into synaptic vesicles Curr. Opin. Neurobiol. 2 1992 586 594
9. J.G. Harris, S. Kongs, D. Allensworth, L. Martin, J. Tregellas, B. Sullivan, G. Zerbe, and R. Freedman Effects of nicotine on cognitive deficits in schizophrenia Neuropsychopharmacology 29 2004 1378 1385
10. T.F. Heatherton, L.T. Kozlowski, R.C. Frecker, and K.O. Fagerstrom The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire Br. J. Addict. 86 1991 1119 1127
11. J.R. Hughes, D.K. Hatsukami, J.E. Mitchell, and L.A. Dahlgren Prevalence of smoking among psychiatric outpatients Am. J. Psychiatry 143 1986 993 997
12. S.R. Kay, A. Fiszbein, and L.A. Opler The Positive and Negative Syndrome Scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276
13. M.J. Lee, C.R. Breese, M.L. Strook, and S. Leonard The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain Brain Res. Mol. Brain Res. 86 2001 115 124
14. K.P. Lesch, J. Gross, B.L. Wolozin, D.L. Murphy, and P. Riederer Extensive sequence divergence between the human and rat brain vesicular monoamine transporter: possible molecular basis for species differences in the susceptibility to MPP+ J. Neural Transm.: Gen. Sect. 93 1993 75 82
15. K.P. Lesch, J. Gross, B.L. Wolozin, E. Franzek, D. Bengel, P. Riederer, and D.L. Murphy Direct sequencing of the reserpine-sensitive vesicular monamine transporter complementary DNA in unipolar depression and manic depressive illness Psychiatr. Genet. 4 1994 153 160
16. L. Naudon, I. Leroux-Nicollet, and J. Costentin Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra Neurosci. Lett. 173 1994 1 4
17. H.A. Pincus, M. First, A. Frances, and L. McQueen Reviewing DSM-IV Am. J. Psychiatry 153 1996 850
18. F.E. Pontieri, G. Tanda, F. Orzi, and G. Di Chiara Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs Nature 382 1996 255 257
19. M. Rehavi, N. Roz, and A. Weizman Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2 Eur. Neuropsychopharmacol. 12 2002 261 268
20. N. Ripoll, M. Bronnec, and M. Bourin Nicotinic receptors and schizophrenia Curr. Med. Res. Opin. 20 2004 1057 1074
21. K. Schwartz, A. Weizman, and M. Rehavi Decreased platelet vesicular monoamine transporter density in habitual smokers Eur. Neuropsychopharmacol. 15 2005 235 238
22. H.H. Stassen, R. Bridler, S. Hagele, M. Hergersberg, B. Mehmann, A. Schinzel, M. Weisbrod, and C. Scharfetter Schizophrenia and smoking: evidence for a common neurobiological basis? Am. J. Med. Genet. 96 2000 173 177
23. M.L. Steinberg, J.M. Williams, H.R. Steinberg, J.A. Krejci, and D.M. Ziedonis Applicability of the fagerstrom test for nicotine dependence in smokers with schizophrenia Addict. Behav. 30 2005 49 59
24. T. Vander Borght, M. Kilbourn, T. Desmond, D. Kuhl, and K. Frey The vesicular monoamine transporter is not regulated by dopaminergic drug treatments Eur. J. Pharmacol. 294 1995 577 583
25. M. Weiser, A. Reichenberg, I. Grotto, R. Yasvitzky, J. Rabinowitz, G. Lubin, D. Nahon, H.Y. Knobler, and M. Davidson Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study Am. J. Psychiatry 161 2004 1219 1223
26. S. Zammit, P. Allebeck, C. Dalman, I. Lundberg, T. Hemmingsson, and G. Lewis Investigating the association between cigarette smoking and schizophrenia in a cohort study Am. J. Psychiatry 160 2003 2216 2221
27. J.K. Zubieta, S.F. Taylor, P. Huguelet, R.A. Koeppe, M.R. Kilbourn, and K.A. Frey Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects Biol. Psychiatry 49 2001 110 116
28. M. Zucker, A. Weizman, and M. Rehavi Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter Life Sci. 69 2001 2311 2317
29. M. Zucker, A. Valevski, A. Weizman, and M. Rehavi Increased platelet vesicular monoamine transporter density in adult schizophrenia patients Eur. Neuropsychopharmacol. 12 2002 343 347